The XOLAIR® \(omalizumab\) Chronic Spontaneous Urticaria \(CSU\) Urticaria Activity Score \(UAS\) Worksheet is a tool that patients can use to track their symptoms. HCP can provide …

The weekly Urticaria Activity Score (UAS7) is a patient-reported outcome (PRO) tool that combines the scores for itch and hive severity to reflect disease activity in patients with chronic …

UAS7: Calculated by summing once-daily UAS scores over a 7-day period, with total scores ranging from 0 to 42. Used to provide a more comprehensive assessment of disease burden …

Three UAS7 scores were computed: UAS7 twice daily (UAS7 TD), UAS7 once daily for maximum itch (UAS7 OD1MAX), and UAS7 once daily for average itch (UAS7 OD2AVG). UAS7 values …

Unsurprisingly, UAS7 (e.g., change from baseline and UAS7 ≤ 6) is the most frequently used PRO [28, 31, 34, 35, 37, 38]. A UAS7 ≤ 6 score is defined as “well-controlled urticaria”, which …

荨麻疹活动性评分Urticaria activity score (UAS) 包括计算风团数量和瘙痒程度。共评价最近7天的情况, 因此总分为42分，2018年一篇文献显示，切点为11分时，它显示的敏感性与特异性分别 …

Two versions of the urticaria activity score used for 7 consecutive days (UAS7) are available: (1) The guideline-recommended UAS7, with once-daily documentation, and (2) the UAS7 TD, with …

The Urticaria Activity Score (UAS) is a CIU-specifi c patient-reported measure. It is based on the assessment of key CIU symptoms: number of wheals and intensity of itch.1 Patients with CIU …

荨麻疹活动评分（UAS）是评估慢性自发性荨麻疹（CSU）患者疾病活动的金标准。 UAS7 和 UAS7TD 两个不同的版本目前用于临床试验和常规护理。 为了比较两个版本并获得关于其可解 …

both versions can generate a weekly score (UAS7), calculated as the sum of the daily number of hives score and the itch severity score over 7 days. UAS7 values range from 0 to 42, with …